Danfang Zhang Selected Research

Danfang Zhang Research Topics

Disease

35	Neoplasms (Cancer) 01/2024 - 01/2006
13	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2006
12	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2008
11	Hypoxia (Hypoxemia) 01/2022 - 05/2007
9	Melanoma (Melanoma, Malignant) 08/2020 - 01/2006
7	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 12/2014
5	Triple Negative Breast Neoplasms 09/2023 - 11/2008
4	Experimental Melanoma 05/2009 - 01/2006
2	Lymphatic Metastasis 10/2022 - 12/2006
2	Carcinoma (Carcinomatosis) 01/2017 - 08/2015
1	Carcinogenesis 01/2024
1	Wounds and Injuries (Trauma) 12/2021
1	Adenoma (Adenomas) 08/2015
1	Colorectal Neoplasms (Colorectal Cancer) 08/2015
1	Lung Neoplasms (Lung Cancer) 04/2015
1	Anemia 10/2014
1	Hepatomegaly 12/2009
1	Splenomegaly 12/2009
1	Pathologic Neovascularization 11/2009
1	Necrosis 05/2009
1	Prostatic Neoplasms (Prostate Cancer) 11/2008

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2007
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 10/2006
6	cadherin 5IBA 01/2019 - 09/2007
5	Small Interfering RNA (siRNA)IBA 01/2022 - 09/2014
5	Messenger RNA (mRNA)IBA 01/2021 - 11/2007
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2008
4	Matrix Metalloproteinases (MMPs)IBA 12/2017 - 10/2006
4	Sunitinib (Sutent)FDA Link 01/2017 - 11/2009
4	VimentinIBA 08/2016 - 11/2008
3	Long Noncoding RNAIBA 01/2024 - 10/2018
3	Eukaryotic Initiation Factor-4EIBA 09/2023 - 12/2021
3	Angiogenesis InhibitorsIBA 01/2017 - 03/2011
3	CateninsIBA 01/2017 - 08/2015
3	Cadherins (E-Cadherin)IBA 08/2016 - 04/2015
3	Oxygen (Dioxygen)IBA 09/2014 - 01/2006
3	ClusterinIBA 03/2012 - 12/2006
3	ParaffinIBA 12/2006 - 01/2006
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2023 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 09/2014
2	Doxycycline (Periostat)FDA LinkGeneric 12/2014 - 11/2007
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2012 - 11/2008
2	Estrogen ReceptorsIBA 03/2012 - 11/2008
2	SuspensionsIBA 11/2007 - 01/2006
1	MicroRNAs (MicroRNA)IBA 10/2022
1	ClaudinsIBA 01/2022
1	CytokinesIBA 01/2022
1	Macrophage Migration-Inhibitory FactorsIBA 01/2022
1	Cell Adhesion MoleculesIBA 12/2021
1	Peptide Initiation Factors (Initiation Factor)IBA 12/2021
1	LigandsIBA 08/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2020
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2019
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2017
1	Sirolimus (Rapamycin)FDA Link 12/2017
1	SialomucinsIBA 01/2017
1	4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA 10/2016
1	Epidermal Growth Factor (EGF)IBA 08/2016
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2016
1	CaspasesIBA 01/2016
1	CalciumIBA 01/2016
1	NestinIBA 01/2016
1	KalininIBA 04/2015
1	Matrix Metalloproteinase 13IBA 04/2015
1	Urokinase Plasminogen Activator ReceptorsIBA 04/2015
1	human ERBB2 proteinIBA 03/2012
1	Estrogens (Estrogen)FDA Link 03/2012
1	Cytostatic AgentsIBA 03/2011
1	Hormones (Hormone)IBA 12/2009
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2009
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2009
1	MorpholinosIBA 11/2009
1	Deoxyribonucleases (DNase)FDA Link 05/2009
1	AntibodiesIBA 04/2009
1	plerixafor FDA Link 11/2008
1	Chemokine CXCL12IBA 11/2008
1	CXCR4 Receptors (CXCR4 Receptor)IBA 11/2008
1	TubulinIBA 11/2008
1	moesinIBA 11/2008
1	GelatinIBA 11/2007
1	Saline SolutionIBA 11/2007
1	Metalloproteases (Metalloproteinases)IBA 09/2007
1	Laminin (Merosin)IBA 09/2007
1	Formaldehyde (Formol)FDA Link 12/2006
1	EndoglinIBA 10/2006
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 01/2006
1	CarbonIBA 01/2006
1	Periodic AcidIBA 01/2006

Therapy/Procedure

8	Therapeutics 08/2020 - 11/2009
2	Drug Therapy (Chemotherapy) 03/2011 - 12/2006
1	Immunotherapy 01/2022
1	Replantation 12/2021
1	Injections 04/2009
1	Lasers (Laser) 07/2007